Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
A Phase 1 Study,in Cystic Fibrosis Patients,of the Safety,Toxicity,and Biological Efficacy of a Single Administration of a Replication Deficient,Recombinant Adenovirus Carrying the cDNA of the Normal Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Lung. National Institutes of Health,Bethesda,Maryland